Terms: = Gastric cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Treatment
5 results:
1. Identification and validation of ferroptosis-related biomarkers and the related pathogenesis in precancerous lesions of gastric cancer.
Kuang Y; Yang K; Meng L; Mao Y; Xu F; Liu H
Sci Rep; 2023 Sep; 13(1):16074. PubMed ID: 37752199
[TBL] [Abstract] [Full Text] [Related]
2. Essential meiotic structure-specific endonuclease1 (
Guo Z; Liang E; Li W; Jiang L; Zhi F
Bioengineered; 2021 Dec; 12(2):9869-9884. PubMed ID: 34719326
[TBL] [Abstract] [Full Text] [Related]
3. mybL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
Deng Q; Wu L; Li Y; Zou L
Adv Clin Exp Med; 2021 Sep; 30(9):957-966. PubMed ID: 34358419
[TBL] [Abstract] [Full Text] [Related]
4. Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human gastric cancer Cells.
Hao S; Yu J; He W; Huang Q; Zhao Y; Liang B; Zhang S; Wen Z; Dong S; Rao J; Liao W; Shi M
Neoplasia; 2017 Dec; 19(12):1022-1032. PubMed ID: 29144989
[TBL] [Abstract] [Full Text] [Related]
5. Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.
Claerhout S; Lim JY; Choi W; Park YY; Kim K; Kim SB; Lee JS; Mills GB; Cho JY
PLoS One; 2011; 6(9):e24662. PubMed ID: 21931799
[TBL] [Abstract] [Full Text] [Related]
